
DLB
Dolby Laboratories Inc
- Overview
- Forecast
- Valuation
- Earnings

Line
|

Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
76.690
Open
76.690
VWAP
76.33
Vol
209.96K
Mkt Cap
7.34B
Low
75.905
Amount
16.03M
EV/EBITDA(TTM)
17.74
Total Shares
95.84M
EV
6.72B
EV/OCF(TTM)
16.02
P/S(TTM)
5.62
Dolby Laboratories, Inc. is engaged in designing and manufacturing of audio and imaging hardware and software products for the cinema, television, broadcast and entertainment industries. The two primary components of its licensing business are Branded Technologies, which include Branded Audio Codecs, Dolby Atmos & Dolby Vision, and Patents, which include Audio Patents and Imaging Patents. The Company's cinema imaging products include digital cinema servers used to load, store, decrypt, decode, watermark, and playback digital film files for presentation on digital cinema projectors and software used to encrypt, encode and package digital media files for distribution. Its cinema audio products include cinema processors, amplifiers and loudspeakers used to decode, render, and optimally play back digital cinema soundtracks, including those using Dolby Atmos. It also offers various services to support theatrical and television production for cinema, broadcast, and home entertainment.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
366.34M
+2.62%
1.150
+0.88%
310.12M
+1.74%
0.773
-4.53%
305.23M
+5.68%
0.713
+0.47%
Estimates Revision
The market is revising Downward the revenue expectations for Dolby Laboratories, Inc. (DLB) for FY2025, with the revenue forecasts being adjusted by -0.19% over the past three months. During the same period, the stock price has changed by 0.45%.
Revenue Estimates for FY2025
Revise Downward

-0.19%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward

-1.24%
In Past 3 Month
Stock Price
Go Up

+0.45%
In Past 3 Month
4 Analyst Rating

34.01% Upside
Wall Street analysts forecast DLB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for DLB is 102.33 USD with a low forecast of 95.00 USD and a high forecast of 112.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
0 Hold
0 Sell
Strong Buy

34.01% Upside
Current: 76.360

Low
95.00
Averages
102.33
High
112.00

34.01% Upside
Current: 76.360

Low
95.00
Averages
102.33
High
112.00
Tigress Financial
Ivan Feinseth
reinstated
$112
2025-05-15
Reason
Tigress Financial
Ivan Feinseth
Price Target
$112
2025-05-15
reinstated
Reason
Barrington Research
Patrick Sholl
Buy
Maintains
$100
2025-02-13
Reason
Barrington Research
Patrick Sholl
Price Target
$100
2025-02-13
Maintains
Buy
Reason
Meeting to be held in Minneapolis on February 11 hosted by Barrington.
Rosenblatt
Steven Frankel
Strong Buy
Maintains
$100
2025-01-30
Reason
Rosenblatt
Steven Frankel
Price Target
$100
2025-01-30
Maintains
Strong Buy
Reason
Barrington Research
Patrick Sholl
Buy
Maintains
$100
2025-01-30
Reason
Barrington Research
Patrick Sholl
Price Target
$100
2025-01-30
Maintains
Buy
Reason
Barrington Research
James Goss
Buy
Maintains
$100
2025-01-27
Reason
Barrington Research
James Goss
Price Target
$100
2025-01-27
Maintains
Buy
Reason
Rosenblatt
Steven Frankel
Strong Buy
Maintains
$100
2025-01-23
Reason
Rosenblatt
Steven Frankel
Price Target
$100
2025-01-23
Maintains
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Dolby Laboratories Inc (DLB.N) is 19.29, compared to its 5-year average forward P/E of 22.71. For a more detailed relative valuation and DCF analysis to assess Dolby Laboratories Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued
5Y Average PE
22.71
Current PE
19.29
Overvalued PE
25.96
Undervalued PE
19.46
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair
5Y Average EV/EBITDA
14.45
Current EV/EBITDA
13.54
Overvalued EV/EBITDA
16.15
Undervalued EV/EBITDA
12.75
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair
5Y Average PS
6.08
Current PS
5.39
Overvalued PS
6.89
Undervalued PS
5.27
Financials
Annual
Quarterly
FY2025Q2
YoY :
+1.38%
369.56M
Total Revenue
FY2025Q2
YoY :
+5.17%
111.97M
Operating Profit
FY2025Q2
YoY :
-6.10%
92.23M
Net Income after Tax
FY2025Q2
YoY :
-6.93%
0.94
EPS - Diluted
FY2025Q2
YoY :
-2.60%
168.00M
Free Cash Flow
FY2025Q2
YoY :
+1.05%
90.30
Gross Profit Margin - %
FY2025Q2
YoY :
+2.71%
29.57
FCF Margin - %
FY2025Q2
YoY :
-7.35%
24.96
Net Margin - %
FY2025Q2
YoY :
+28.72%
10.22
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
8.8M
USD
7
3-6
Months
2.1M
USD
2
6-9
Months
15.0M
USD
9
0-12
Months
2.1M
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
9.6K
Volume
1
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
1
18.1K
Volume
Months
6-9
2
125.6K
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
8.8M
USD
7
3-6
Months
2.1M
USD
2
6-9
Months
15.0M
USD
9
0-12
Months
2.1M
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
DLB News & Events
Events Timeline
2025-06-24 (ET)
2025-06-24
05:07:40
Dolby, Audi announce partnership to integrate Dolby Atmos

2025-06-23 (ET)
2025-06-23
09:09:52
Dolby, Lenovo, Google unveil new Lenovo Chromebook Plus

2025-05-01 (ET)
2025-05-01
16:39:17
Dolby sees FY25 non-GAAP EPS $3.88-$4.03, consensus $4.04

Sign Up For More Events
Sign Up For More Events
News
9.5
07-08PRnewswireDolby Laboratories Announces Conference Call and Webcast for Q3 Fiscal 2025 Financial Results
6.5
06-30NASDAQ.COMTop Research Reports for Meta Platforms, ServiceNow & Booking
7.5
06-24NewsfilterDolby and Audi announce partnership to integrate Dolby Atmos
Sign Up For More News
People Also Watch

TREX
Trex Company Inc
68.490
USD
+0.96%

CHRD
Chord Energy Corp
108.720
USD
-0.80%

ALV
Autoliv Inc
117.350
USD
+1.29%

CAE
CAE Inc
28.680
USD
+0.63%

SNV
Synovus Financial Corp
49.610
USD
-12.54%

ICL
ICL Group Ltd
6.800
USD
-0.58%

GIL
Gildan Activewear Inc
52.250
USD
+0.19%

IVZ
Invesco Ltd
21.810
USD
+1.77%

ASND
Ascendis Pharma A/S
167.470
USD
-0.50%

MIDD
Middleby Corp
149.700
USD
+0.84%
FAQ

What is Dolby Laboratories Inc (DLB) stock price today?
The current price of DLB is 76.36 USD — it has increased 0.04 % in the last trading day.

What is Dolby Laboratories Inc (DLB)'s business?

What is the price predicton of DLB Stock?

What is Dolby Laboratories Inc (DLB)'s revenue for the last quarter?

What is Dolby Laboratories Inc (DLB)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Dolby Laboratories Inc (DLB)'s fundamentals?

How many employees does Dolby Laboratories Inc (DLB). have?
